Northland Biotech Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
180
- Latest Deal Type
-
IPO
Northland Biotech General Information
Description
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.
Contact Information
Website
www.northland-bio.comCorporate Office
- A406, Zhongguancun Biomedical Park
- No. 5 Shangdi Kaixing Road, Haidian District
- Beijing
- China
Corporate Office
- A406, Zhongguancun Biomedical Park
- No. 5 Shangdi Kaixing Road, Haidian District
- Beijing
- China
Northland Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. IPO | 15-Nov-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 09-Jan-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 24-Mar-2016 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 02-Jul-2014 | $11.6M | $11.6M | Completed | Generating Revenue | |
| 1. IPO | 18-Feb-2009 | Completed | Profitable |
Northland Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 7,230,000 | $1.45 | $1.45 | 1x | $1.45 | 6.45% |
Northland Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Northland Biotech Patents
Northland Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3909974-A4 | Human hepatocyte growth factor mutant and uses thereof | Pending | 07-Jan-2019 | ||
| EP-3909974-A1 | Human hepatocyte growth factor mutant and uses thereof | Pending | 07-Jan-2019 | ||
| US-20220064242-A1 | Human hepatocyte growth factor mutant and uses thereof | Active | 07-Jan-2019 | ||
| US-12264186-B2 | Human hepatocyte growth factor mutant and uses thereof | Active | 07-Jan-2019 | ||
| US-7816321-B2 | Treating skin lesions, heart injuries, corneal lesions and/or coronary heart disease | Active | 15-Jul-2005 | C07K14/57581 |
Northland Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Northland Biotech Investments (1)
Northland Biotech’s most recent deal was a Joint Venture with Joint Venture (Epi Biotech / Northland Biotech). The deal was made on 14-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Epi Biotech / Northland Biotech) | 14-Apr-2025 | Joint Venture | Clinics/Outpatient Services |
Northland Biotech FAQs
-
When was Northland Biotech founded?
Northland Biotech was founded in 2004.
-
Where is Northland Biotech headquartered?
Northland Biotech is headquartered in Beijing, China.
-
What is the size of Northland Biotech?
Northland Biotech has 180 total employees.
-
What industry is Northland Biotech in?
Northland Biotech’s primary industry is Drug Discovery.
-
Is Northland Biotech a private or public company?
Northland Biotech is a Private company.
-
What is Northland Biotech’s current revenue?
The current revenue for Northland Biotech is .
-
How much funding has Northland Biotech raised over time?
Northland Biotech has raised $26.3M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
